Medical Program: FDA-Approved Gene Therapy Could Reverse Blindness in Children & Adults

FDA-Approved Gene Therapy Reverses Blindness in Children & Adults

FDA-Approved Gene Therapy Reverses Blindness in Children & Adults
RestartResume
The FDA recently approved the first worldwide treatment for inherited blindness. Join us as we discuss this groundbreaking discovery.
  • Overview

    Power couple Drs. Jean Bennett and Albert Maguire discuss how their new therapy for the RPE65 gene, which causes retinal blindness, was recently approved by the FDA to become the first gene therapy treatment for a genetic disease in the United States and the first worldwide treatment for inherited blindness. Not only do they delve into the mechanics of the corrected gene injection, but they also explain what this milestone means for patient eligibility and how their marriage has played a role in the success of their research partnership.

    Dr. Jean Bennett is the F.M. Kirby Professor of Ophthalmology at the Perelman School of Medicine at the University of Pennsylvania, and Dr. Albert Maguire is a Professor of Ophthalmology at the Hospital of the University of Pennsylvania and Attending Physician in the Division of Pediatric Ophthalmology at Children’s Hospital of Philadelphia.

     

Facebook Comments

Sign-up for the Prova Education newsletters.

Better education for a better you.

* Required
Optional